snyderman nancy lynn MD
- SEC CIK
- 0001675198
In the past year, 1 open-market sale filing worth $2.24M and no purchases.
Current role at each company
- ALKS Alkermes plc.Directoras of Aug 3, 2026
- LYRA Lyra Therapeutics, Inc.Directoras of May 16, 2025
- AXNX Axonics, Inc.Directoras of Nov 15, 2024
- FHLTU Future Health ESG Corp.Directoras of Oct 26, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $2.24M
- 1 filing
- Net
- −$2.24M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists snyderman nancy lynn MD as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ALKS Alkermes plc.
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 8, 2022 (view filing) | Mar 4 | 4 days | snyderman nancy lynn MDDirector | PPurchase | +427 | $23.43 | +$10.0K | +4.8%9.37K after | |
| Aug 3, 2026 (view filing)7:16 PM ET | Aug 3 | Same day | snyderman nancy lynn MDDirector | SSale | −44.5K | $50.35 | −$2.24M | −74.3%15.4K after |
FHLTU Future Health ESG Corp.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 16, 2021 (view filing) | Sep 14 | 2 days | snyderman nancy lynn MDDirector | PPurchaseWarrant | +27.4K | $1.00 | +$27.4K | –27.4K after | Derivative |